Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending July 24, 2006. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding Ordinary Shares of the Company.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory disclosure of share transactions and does not contain financial performance data.
Material Changes
The filing details specific changes in share interests within the GlaxoSmithKline Employee Trust ("GSK Trust") on July 19, 2006:
- The GSK Trust transferred 11,142 Ordinary Shares to participants in the SmithKline Beecham Employee Share Option Plan 1991.
- The GSK Trust received 1,534 Ordinary Shares due to the reversal of an incorrect exercise.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It notes that three directors (Dr J-P Garnier, Dr M M Slaoui, and Mr J S Heslop) are interested in shares held in the GSK Trust in the same capacity as other employees. The transactions were notified in accordance with Disclosure Rule 3.1.4R(1)(b).
Investor Verification Points
- Verify the impact of the 11,142 share transfers on the outstanding share count for the SmithKline Beecham Employee Share Option Plan 1991.
- Confirm the details of the 1,534 share reversal to ensure accurate record-keeping of the GSK Trust holdings.
- Review the specific interests of Directors Dr J-P Garnier, Dr M M Slaoui, and Mr J S Heslop in the GSK Trust as disclosed.